6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan|

The Department of Veterans Affairs Network Contracting Office 8 issued a firm-fixed price requirements contract under solicitation number 36C24826Q0337 to procure Thyroid Cancer Molecular Test services for the Orlando VA Healthcare System and the Caribbean VA Healthcare System. The contract, which includes a base year and four one-year option periods, has a potential duration of up to five years with an additional six-month extension available under FAR 52.217-8. The total estimated value is based on a guaranteed minimum of $1,000 for the base year, though the full potential value approaches $41.5 million, corresponding to the NAICS code 621511 and its associated small business size standard. Testing must be performed in a CLIA-certified and CAP-accredited laboratory, with results delivered within 5–7 business days of specimen receipt, detailing genomic alterations such as BRAF, RAS, RET/PTC, and PAX8/PPARγ, aligned with current clinical guidelines. Specimens are shipped from San Juan, PR, and Orlando, FL, with FOB destination terms and all shipping costs, including collection materials and packaging, borne by the contractor. The contract mandates HIPAA-compliant handling of Protected Health Information under a Business Associate Agreement, tamper-evident packaging, chain-of-custody documentation, and secure delivery via U.S. registered mail. Invoicing must be submitted electronically through VA’s EIPP system using X12 EDI formats, with payment processed via electronic funds transfer in accordance with FAR 52.232-33 and VAAR 852.232-72. Evaluation of proposals will prioritize Technical Acceptability—assessing clinical efficacy, sensitivity, specificity, validation through multi-center trials, and diagnostic performance—followed by Past Performance and Price, with the government reserving the right to select the highest-value offer under a trade-off approach rather than Lowest Price Technically Acceptable. Offerors must submit two electronic volumes: one containing pricing details on the SF-1449 and Section B.2, and the other containing technical documentation, including manufacturer specifications, three years of similar service experience, and evidence of capability to detect thyroid cancer genomic markers. All proposals must be emailed to yolanda.glover@va.gov by March 9, 2026, at 4:00 PM EST, not exceeding 20MB in size